You got pumped and dumped, page-27

First 27 Last

Share
Profile

Follow
leoburner

64 Posts.

19

07/05/18

22:20

Post #: 32940667
Share

Originally posted by leoburner ↑

Competition in the dispensary market is high, but the barriers to entry for growers is actually really high as well. Growers need to purchase their facility and come up with strong business plan before they can put in a growers licence proposal. The time it takes to be approved either bankrupts most businesses before they start due to the cost of renting the facility for they just start growing for the black market.

For the most part, only the larger corporate companies have the financial backing to see their growers projects to commercial production.

I actually agree, with you, Aurora will be more like $20-30 billion, due to the fact that by increasing production, the average sale price will decrease and there will be diminishing returns. Although, I believe I read that Aurora secured another growing site in Germany. Germany is meant to have a lot of cannabis smokers, plus it has 2.5 times the people of Canada, so there is a few factors to consider.

As for Cann Group, I am an analyst that covered the stock, and my numbers suggest that if Cann group were to become an oligopoly, with combined 14760 square meters of growing area, the company will produce around 38 tonnes of cannabis retailing for $11/gram, the revenue would be $355 million, profit would be around $150 million. At a PE of 20 the market cap would be $3 billion and the stock price would be at $21.

If a takeover were to happen, there would only be limited upside for investors (give or take 30%).

Expand

I messed my numbers up, 25 tonne cannabis/pa, $11/gram, $303 mil rev, $136 mil NPAT, pe of 22, market cap of $3 mil, share price +$20.

With my highest scenario being about $27 in FY2021-22

If its a public company at that time, I think $20-27.

CAN Price at posting: $3.57 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

There are more pages in this discussion • 53 more messages in this thread...

First 27 Last

Add CAN (ASX) to my watchlist

(20min delay)
Last 3.1¢		Change 0.001(3.33%)		Mkt cap ! $14.47M

Open	High	Low	Value	Volume
3.0¢	3.2¢	3.0¢	$32.13K	1.035M

Buyers (Bids)

No.	Vol.	Price($)
15	1259746	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	53594	1

View Market Depth

No.	Vol.	Price($)
15	1259746	0.030
7	137274	0.029
4	889642	0.028
5	205555	0.027
2	146000	0.026

Price($)	Vol.	No.
0.031	53594	1
0.032	365674	9
0.033	664176	7
0.034	83720	2
0.035	113057	7

Last trade - 15.28pm 17/07/2024 (20 minute delay)

CAN (ASX) Chart

You got pumped and dumped, page-27

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You got pumped and dumped, page-27

Top Stories

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News